Dietary Supplement Recall: TestoFREAK Contains Sub-Potent Zinc Levels
VRA Formulations is recalling TestoFREAK Maximize Testosterone Dietary Supplement due to sub-potent zinc content. Affected bottles were distributed domestically through internet sales.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class III recall addresses a labeling and potency issue rather than a direct safety hazard. Sub-potent zinc content renders the product less effective than represented, but poses no immediate health risk, consistent with minor efficacy and labeling concerns.
Plain-English summary
VRA Formulations LLC is recalling TestoFREAK Maximize Testosterone Dietary Supplement. The product is supplied as 60 capsules per dark amber bottle, with 100 bottles per case.
The recall was initiated due to sub-potent levels of zinc in the product. Affected lot number 21112002 (Expiration Date 12/2024) contains less zinc than claimed on the label.
A total of 1,569 bottles were distributed domestically through internet sales only.
Consumers who have purchased this product should discontinue use. Anyone with questions should consult a healthcare provider.
The recalled product
- Product
- TestoFREAK Maximize Testosterone Dietary Supplement 60 capsules per dark amber bottle, 100 bottles per case
- Manufacturer
- VRA FORMULATIONS LLC
- Category
- Food — Dietary Supplement
- Affected units
- 1,569
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot Numbers 21112002 Expiration Date: 12/2024
Distribution
Distribution scope not specified by the agency.
Related recalls
Same hazard · sub potency
See all →- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- HighLorazepam tablets recalled due to failed potency and impurity specifications
FDA (Drugs) · 2025-02-26
- HighLorazepam Tablets Recalled for Failed Impurity and Potency Specifications
FDA (Drugs) · 2025-02-26
- LowSinuFrin Nasal Decongestant Recalled for Sub-Potency Nationwide
FDA (Drugs) · 2024-07-03
- SeverePrescription Drug Javygtor Recalled for Sub-Potency and Powder Discoloration
FDA (Drugs) · 2024-05-15